UV Detectable [18F]Fluoride Cryptate Complexes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing radiopharmaceuticals like 18F-FDG for PET imaging face challenges in achieving rapid and efficient radiolabeling due to the reactivity of fluoride ions, which requires anhydrous conditions and complex handling of potassium ions, leading to potential solvent interference and residual phase-transfer reagent contamination.
Innovation Solution
Development of UV detectable potassium [18F]fluoride diaryl- and aryl-fused [2.2.2]cryptate complexes that enhance the reactivity of fluoride ions and allow for improved detection and reduced solvent interference, facilitating reliable assessment and automation in radiolabeling processes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional phase-transfer reagents are used for radiolabeling, then fluoride ion reactivity is enhanced, but residual reagent contamination increases
Solution Approach 1:
The patent extracts the harmful residual reagent contamination by designing cryptate complexes where the phase-transfer reagent is covalently bound to the fluoride ion through a leaving group, allowing the reagent to be taken out with the fluoride during the reaction and subsequently removed more efficiently, reducing residual contamination in the final radiopharmaceutical product
Solution Approach 2:
The patent introduces an intermediary molecule (the cryptate complex with leaving group) that mediates between the fluoride ion and the substrate. This intermediary enhances fluoride reactivity by pre-organizing the nucleophile while allowing controlled release and subsequent removal of the reagent components, reducing residual contamination
2Productivity
If anhydrous conditions are maintained for radiolabeling, then reaction efficiency improves, but process complexity and handling difficulty increase
Solution Approach 1:
The patent changes the chemical parameters of the system by using cryptate complexes with specific leaving groups that allow the reaction to proceed efficiently with reduced stringency for anhydrous conditions. The modified cryptate structures enable controlled water tolerance while maintaining high radiolabeling efficiency, simplifying the handling requirements
3Measurement precision
If detection sensitivity is improved for radiolabeling assessment, then quality control enhances, but solvent interference increases
Solution Approach 1:
The patent applies local quality by designing cryptate complexes with specific UV-absorbing chromophores attached to the cryptand structure. These localized UV-active groups provide strong detection signals at wavelengths where common radiolabeling solvents have minimal absorption, enabling sensitive detection while avoiding solvent interference through selective wavelength measurement
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The UV detectable [18F]fluoride cryptate complexes enable more efficient radiolabeling with reduced residual phase-transfer reagent contamination, enhancing the quality and reliability of PET imaging agents by providing stronger UV absorbance and improved solubility, thus improving the detection and imaging capabilities.
Implementation Method 1
UV detectable (λ>210 nm) potassium [18F]fluoride diaryl- and aryl-fused [2.2.2]cryptate complexes
Data Source
AI summary
The present invention claims UV detectable (λ>210 nm) potassium [18F]fluoride diaryl- and aryl-fused [2.2.2]cryptate complexes suitable for performing radio-labeling reactions to generate [18F] fluorinated species.